Hydroxychloroquine Globally:— Mike Coudrey (@MichaelCoudrey) March 28, 2020
-India, Hungary & the United Kingdom ban export of the drug to save supply for themselves
-Jordan + France authorize use of hydroxychloroquine to treat COVID-19
-Bahrain claims success with drug on coronavirus patients
-US FDA approves off-label use
Thousands of doctors agree hydroxychloroquine is best treatment for patients infected with coronavirus (COVID19).https://t.co/eFAplBzvgc— Global Awareness 101 (@Mononoke__Hime) April 5, 2020
6770 Doctors in 30 countries were polled and all agreed #Hydroxychloroquine is currently the most effective COVID-19 treatment.— Mike Coudrey (@MichaelCoudrey) April 6, 2020
Yet the media and prominent Democrats are attempting to smear, discredit, and block this life saving treatement.
Why?https://t.co/GrZylvGxJ0
New York Post
written by By Natalie O'Neill
Thursday April 2, 2020
An international poll of thousands of doctors rated the Trump-touted anti-malaria drug hydroxychloroquine the best treatment for the novel coronavirus.
Of the 6,227 physicians surveyed in 30 countries, 37 percent rated hydroxychloroquine the “most effective therapy” for combating the potentially deadly illness, according to the results released Thursday.
The survey, conducted by the global health care polling company Sermo, also found that 23 percent of medical professionals had prescribed the drug in the US — far less than other countries.
“Outside the US, hydroxychloroquine was equally used for diagnosed patients with mild to severe symptoms whereas in the US it was most commonly used for high risk diagnosed patients,” the survey found.
The medicine was most widely used in Spain, where 72 percent of physicians said they had prescribed it.
A debate about hydroxychloroquine was sparked two weeks ago after President Trump touted the drug as a possible “game-changer” in the fight against the COVID-19 pandemic, prompting critics to accuse him of peddling unproven, untested remedies.
To date, “there is no evidence” that any medicine “can prevent or cure the disease,” according to the World Health Organization.
But Sermo CEO Peter Kirk called the polling results a “treasure trove of global insights for policymakers.”
“Physicians should have more of a voice in how we deal with this pandemic and be able to quickly share information with one another and the world,” he said in a press release.
The 30 countries where doctors were surveyed included Europe, South America and Australia — and no incentives were provided to participate, the company said.
— Global Awareness 101 (@Mononoke__Hime) April 3, 2020An international poll of more than 6,000 doctors released Thursday found that the antimalarial drug hydroxychloroquine was the most highly rated treatment for the novel coronavirus. [4/02/2020] https://t.co/Y1FfEJsxyw
The Washington Times
written by Valerie Richardson
Thursday April 2, 2020
An international poll of more than 6,000 doctors released Thursday found that the antimalarial drug hydroxychloroquine was the most highly rated treatment for the novel coronavirus.
The survey conducted by Sermo, a global health care polling company, of 6,227 physicians in 30 countries found that 37% of those treating COVID-19 patients rated hydroxychloroquine as the “most effective therapy” from a list of 15 options.
Of the physicians surveyed, 3,308 said they had either ordered a COVID-19 test or been involved in caring for a coronavirus patient, and 2,171 of those responded to the question asking which medications were most effective.
The U.S. Food and Drug Administration gave chloroquine and its next-generation derivative, hydroxychloroquine, emergency-use authorization Monday for treating the novel coronavirus, although the drug was already being used off-label by some doctors and hospitals for COVID-19 patients.
The survey also found that the most commonly prescribed treatments are analgesics (56%), azithromycin (41%) and hydroxychloroquine (33%).
Azithromycin, known by the brand name Zithromax or Z-Pak, was rated the second-most effective therapy at 32%, followed by “nothing,” analgesics (including acetaminophen), anti-HIV drugs and cough medicine.
Hydroxychloroquine, which is sold under the brand name Plaquenil, was prescribed mainly in the United States for the most severe cases, but not so in other countries.
“Outside the U.S., hydroxychloroquine was equally used for diagnosed patients with mild to severe symptoms whereas in the U.S. it was most commonly used for high risk diagnosed patients,” the survey found.
The 30 nations surveyed included those in Europe, Asia, North America and South America, as well as Australia. No incentives were provided to participate in the poll, conducted March 25-27, according to Sermo.
ANNOUNCEMENT: To create a centralized & dynamic knowledge base we published results of our COVID-19 study, which over 6.2K physicians in 30 countries participated in: https://t.co/ppewwdo8wl pic.twitter.com/Fg5B6FMUCQ— Sermo (@Sermo) April 2, 2020
Hydroxychloroquine usage was most widespread in Spain, where 72% of physicians surveyed said they had prescribed it, followed by Italy at 49%, and least popular in Japan, where 7% had used it to treat COVID-19.
The poll found 23% of U.S. medical professionals had prescribed the drug, which has been FDA-approved for malaria, lupus and rheumatoid arthritis.
Debate about hydroxychloroquine has raged in the United States since President Trump touted it two weeks ago as a potential “game-changer” in the fight against the deadly pandemic, prompting critics to accuse him of peddling unproven remedies, or “snake oil,” as USA Today put it.
Trump-touted malaria drug takes center stage in coronavirus treatment fracas - https://t.co/LnIKLHZYXI - @washtimes #hydroxychloroquine #chloroquine #COVID19— Valerie Richardson (@ValRichardson17) April 2, 2020
Sermo CEO Peter Kirk called the polling results a “treasure trove of global insights for policy makers.”
“Physicians should have more of a voice in how we deal with this pandemic and be able to quickly share information with one another and the world,” he said. “With censorship of the media and the medical community in some countries, along with biased and poorly designed studies, solutions to the pandemic are being delayed.”
The survey also found that 63% of U.S. physicians believe restrictions should be lifted in six weeks or more, and that the epidemic’s peak is at least 3-4 weeks away.
The survey also found that 83% of global physicians anticipate a second global outbreak, including 90% of U.S. doctors but only 50% of physicians in China.
On average, U.S. coronavirus testing takes 4-5 days, while 10% of cases take longer than seven days. In China, 73% of doctors reported getting rest results back in 24 hours.
In cases of ventilator shortages, all countries but China said the top criteria should be patients with the best chance of recovery (47%), followed by patients with the highest risk of death (21%), and then first responders (15%).
In China, the survey said doctors prioritized patients at greatest risk of death.
HUGE DEVELOPMENT: Now 3 international studies find Hydroxycloroquine with Azithromycin show 100% success rate in treating Coronavirus.https://t.co/DbbUjj1osb— Michael Coudrey (@MichaelCoudrey) March 27, 2020
The Gateway Pundit
written by Jim Hoft
Thursday March 19, 2020
HUGE BREAKING NEWS—
There are now THREE international studies — China, Australia and France — that found that Chloroquine with Azithromycin Shows 100% Success Rate in Treating Coronavirus in 6 Days!
We have reported on the success of Chloroquine earlier today and this week.
U.S. House Rep. Dr. Mark Green explains why Z-pak works in conjunction with the Chloroquine in this video.https://t.co/rndX3nDbMP— COVID-19 Reveals People's Inner Fascist! (@TruthIsMySword) March 20, 2020
UPDATE:— Gregory Rigano (@RiganoESQ) March 18, 2020
Full peer reviewed study has been released by Didier Raoult MD, PhD https://t.co/DzFTv13wYn.
After 6 days 100% of patients treated with HCQ + Azithromycin were virologically cured
p-value <.0001https://t.co/vttAIWbPwJ
President Trump announced on Thursday morning that the CDC had approved use of the drug in treating coronavirus patients.
But tonight we heard more from Rep. Mark Green, a former Army Flight Surgeon, that the combination of Chloroquine with Azithromycin cleared the virus in 3 days in 100% of the patients in the study.
That is THREE international studies now that show the success of the Chloroquine treatment.
Hydroxychloroquine & azithroymycin are both very cheap medicines & both are out of patent.— Mike Coudrey (@MichaelCoudrey) April 6, 2020
Without insurance, the 10 day treatment costs about $100.
Closely examine who is trying to discredit this drug.
They would rather push patented vaccines instead.
#Hydroxychloroquine
UPDATE 4/7/20 at 1:16am: Added info below.Another paper on positive results of #Chloroquine-Azithromycin intervention in #Covid_19 patients. Impressive results and reduction in viral load and early discharge! https://t.co/qAGambszbf pic.twitter.com/9oSu6vzhDV— John C. Menzies (@John_Menzies) March 28, 2020
Sanofi (which is donating its supply to France, anyway) sold the U.S. rights to Plaquenil to Covis in 2013, acquired by Concordia in 2015 https://t.co/nRd2WrxImq— Phil Kerpen (@kerpen) April 7, 2020
Developed by Sanofi, hydroxychloroquine is being produced by various companies in generic form after its patent expiration. Sanofi will provide millions of doses for the treatment of about 300,000 Covid-19 patients in France.https://t.co/kVgoEcnyc3— Global Awareness 101 (@Mononoke__Hime) April 7, 2020
No comments:
Post a Comment